Literature DB >> 3583367

Hyper-IgE syndrome.

T Yanagi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3583367     DOI: 10.1007/bf02750794

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  8 in total

1.  Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E.

Authors:  R E Van Scoy; H R Hill; R E Ritts; P G Quie
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

2.  Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis.

Authors:  H R Hill; P B Williams; G G Krueger; B Janis
Journal:  Ann Intern Med       Date:  1976-07       Impact factor: 25.391

3.  Defective neutrophil chemotaxis and hyperimmunoglobulinemia E-a reversible defect?

Authors:  G Fontan; F Lorente; M C Garcia Rodriguez; J A Ojeda
Journal:  Acta Paediatr Scand       Date:  1976-07

4.  Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections.

Authors:  H R Hill; P G Quie
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

5.  Extreme hyperimmunoglobulinemia E and undue susceptibility to infection.

Authors:  R H Buckley; B B Wray; E Z Belmaker
Journal:  Pediatrics       Date:  1972-01       Impact factor: 7.124

6.  Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia, and divergent chemotactic responses in two generations.

Authors:  R Blum; G Geller; L A Fish
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

7.  Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections.

Authors:  K Schopfer; K Baerlocher; P Price; U Krech; P G Quie; S D Douglas
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

8.  Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome.

Authors:  R S Geha; E Reinherz; D Leung; K T McKee; S Schlossman; F S Rosen
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.